When patients begin receiving care at St. Luke's Same Day Surgery Center in April, they'll receive medications through a computerized pharmacy system that's been in use throughout St. Luke's Regional ...

On Wednesday, Pyxis Oncology, Inc. (NASDAQ:PYXS) released preliminary data from the ongoing Phase 1 clinical dose escalation study evaluating PYX-201 in multiple solid tumors. Among evaluable Head and ...

Stephens has initiated coverage on Pyxis Oncology Inc (NASDAQ:PYXS), highlighting the company’s technology platform aimed at developing next-gen antibody-drug conjugates (ADCs) with enhanced potency, ...

Investing.com - Jefferies raised its price target on Pyxis Oncology Inc. (NASDAQ:PYXS) to $8.00 from $7.40 while maintaining a Buy rating on the stock. The new target represents significant upside ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced the European launch of its BD Pyxis Pro Dispensing Solution and BD Incada Connected Care Platform. This new-generation ...